Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Dedifferentiated Liposarcoma (DDLPS), Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06422806
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:05.391518+00:00
Published At
2026-04-22T00:00:00+00:00
Record Updated At
2026-04-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Dedifferentiated Liposarcoma", "Metastatic Undifferentiated Pleomorphic Sarcoma", "Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8", "Unresectable Dedifferentiated Liposarcoma", "Unresectable Undifferentiated Pleomorphic Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-22"
protocolSection.identificationModule.nctId
"NCT06422806"
protocolSection.identificationModule.officialTitle
"A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Dedifferentiated Liposarcoma (DDLPS), Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Metastatic Dedifferentiated Liposarcoma (protocolSection.conditionsModule.conditions)
  • Metastatic Undifferentiated Pleomorphic Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Dedifferentiated Liposarcoma (protocolSection.conditionsModule.conditions)
  • Unresectable Undifferentiated Pleomorphic Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.